See the PDF Version Here:
The COVID-19 hydroxychloroquine story PDF
The malaria, arthritis and lupus drug, hydroxychloroquine* has been showing enormous promise in the treatment of COVID-19.
That’s why The Palmer Foundation is making resources available to fund clinical trials, scale up the availability of hydroxychloroquine as soon as we can, and have enough of the drug available for all Australians, free of charge.
Follow along with extraordinary developments happening worldwide at a rapid pace.
While this list is by no means exhaustive, it is indicative of the progress being made.
The Palmer Foundation has acquired 32.9 million doses of hydroxychloroquine for treating Australians, free of charge.
Part of this is a significant quantity of the active pharmaceutical ingredient, which will enable the manufacture of the tablets right here in Australia.